Supplement
Sorghum grain clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
Written with another drug
- Jobelyn
- 3
Studies by the year they started
5 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
Lagos State University (3) · Natural Immune Systems Inc (1) · Federal Neuro-Psychiatric Hospital, Yaba (1)
Often tested with
Tested in the same studies.
Sorghum bicolor Supplement (5) · Proguanil (2) · Folic Acid (2)
Studies
Open first, then newest update. How each study uses sorghum grain is read from its arms, and is right about nine times in ten.
Testing it · 5
- Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of SchizophreniaStatus unknownPhase 1/2Federal Neuro-Psychiatric Hospital, YabaNCT02240173Written as Jobelyn
- The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological PatientsCompletedPhase 2Lagos State UniversityNCT01670955Written as Jobelyn
- Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic PopulationCompletedPhase 1/2Natural Immune Systems IncNCT01828060Written as Jobelyn™
- Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)Status unknownPhase 1/2Lagos State UniversityNCT01704794Written as Folic Acid + Paludrine + Jobelyn (500mg)
- The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell AnemiaCompletedPhase 1/2Lagos State UniversityNCT01703104Written as Paludrine + Folic Acid + Jobelyn
Codes
What other systems call sorghum grain · ClinicalTrials.gg INT016253
- RxNorm 1338933One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1338933 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.